454 related articles for article (PubMed ID: 2582313)
21. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
Kjaer M; Fischerman K
Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
[TBL] [Abstract][Full Text] [Related]
22. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
Abbasciano V; Graziano L; Arcudi D; Tassinari D; Nielsen I; Sartori S
Recenti Prog Med; 1991 Oct; 82(10):517-9. PubMed ID: 1684676
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
[TBL] [Abstract][Full Text] [Related]
24. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants.
Herlyn M; Shen JW; Sears HF; Civin CI; Verrill HL; Goldberg EM; Koprowski H
Clin Exp Immunol; 1984 Jan; 55(1):23-35. PubMed ID: 6198117
[TBL] [Abstract][Full Text] [Related]
25. Carcinoembryonic antigen in benign and malignant diseases of the digestive tract.
Zamcheck N; Moore TL; Dhar P; Kupchik HZ; Sorokin JJ
Natl Cancer Inst Monogr; 1972 Dec; 35():433-9. PubMed ID: 4659055
[No Abstract] [Full Text] [Related]
26. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
[TBL] [Abstract][Full Text] [Related]
27. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology].
Patai A; Héber S; Döbrönte Z; Kovács LG
Orv Hetil; 1992 May; 133(21):1301-4, 1307. PubMed ID: 1603581
[TBL] [Abstract][Full Text] [Related]
29. Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age.
Basso D; Fabris C; Del Favero G; Angonese C; Meggiato T; Infantino A; Plebani M; Piccoli A; Leandro G; Burlina A
Dis Markers; 1988; 6(3):203-7. PubMed ID: 3168400
[TBL] [Abstract][Full Text] [Related]
30. Plasma carcinoembryonic antigen in an Australian hospital population.
Frost MA; Coates AS
Med J Aust; 1976 Jun; 1(25):950-3. PubMed ID: 979758
[TBL] [Abstract][Full Text] [Related]
31. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
Schneider J; Schulze G
Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
[TBL] [Abstract][Full Text] [Related]
32. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms].
Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P
Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188
[TBL] [Abstract][Full Text] [Related]
33. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
Klapdor R; Klapdor U; Bahlo M; Dallek M; Kremer B; van Ackeren H; Schreiber HW; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1949-54. PubMed ID: 6595110
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
35. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
Harmenberg U; Wahren B; Wiechel KL
Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
[TBL] [Abstract][Full Text] [Related]
36. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
Pecchio F; Ricci E; Rapellino M; Oliaro A; Adamo MR; Marzola G; Piantino P
Minerva Med; 1987 Feb; 78(3):141-4. PubMed ID: 3469541
[TBL] [Abstract][Full Text] [Related]
37. [Carcinoembryonic antigen (CEA) and non-oncological liver diseases (case report)].
Bulfoni A; Geatti O; Gobbato F; Turrin D
Arch Sci Med (Torino); 1980; 137(4):579-84. PubMed ID: 7247673
[TBL] [Abstract][Full Text] [Related]
38. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
[TBL] [Abstract][Full Text] [Related]
39. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of carcinoembryonic antigen, gastrointestinal cancer-associated antigen and alphafetoprotein in staging and management of patients with advanced carcinoma of the stomach.
Szymendera JJ; Szawlowski AW; Nowacki MP; Kowalska M; Kaminska JA; Kozlowicz-Gudzinska I
Int J Biol Markers; 1987; 2(1):19-24. PubMed ID: 2448400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
